Form 4: U.S. Physical Therapy Director Regg E. Swanson Reports Acquisition of Restricted Stock

Sentiment:

SEC Form 4


Director Regg E. Swanson acquired 1,424 shares of restricted stock in U.S. Physical Therapy Inc. on May 20, 2024, and beneficially owns 11,304 shares directly and 7,596 shares indirectly through a trust.

Summary

  • On May 20, 2024, Regg E. Swanson, a director of U.S. Physical Therapy Inc., acquired 1,424 shares of common stock.
  • These shares were granted as restricted stock under the company's Amended and Restated 2003 Stock Incentive Plan.
  • The restrictions on these shares will lapse in four equal installments of 356 shares each on July 1, 2024, October 1, 2024, January 1, 2025, and April 1, 2025, contingent upon Swanson's continued service as a director.
  • Following the transaction, Swanson directly owns 11,304 shares and indirectly owns 7,596 shares through the Regg E. Swanson Revocable Trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of restricted stock is a common practice and generally viewed as a positive incentive for directors. There are no negative aspects highlighted in the filing.

Positives

  • The grant of restricted stock aligns the director's interests with those of the company and its shareholders.
  • The vesting schedule encourages continued service as a director.

Risks

  • The vesting of the restricted stock is contingent upon Swanson's continued service as a director, creating a potential risk if he were to leave the board before all shares vest.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the restricted stock.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency regarding the alignment of management's interests with shareholders.

Comparison to Industry Standards

  • Stock grants to directors are a common practice in publicly traded companies to incentivize performance and align interests with shareholders.
  • The vesting schedule of the restricted stock is typical, with vesting occurring over a period of time contingent upon continued service.
  • Companies like Select Medical Holdings Corporation (SEM) and Encompass Health Corporation (EHC) also utilize stock-based compensation for their directors and executives.

Stakeholder Impact

  • The granting of restricted stock aligns the director's interests with those of the shareholders.
  • The vesting schedule encourages the director's continued service, which can benefit the company and its stakeholders.

Key Dates

DateDescription
05/20/2024Date of transaction: Regg E. Swanson acquired 1,424 shares of restricted stock.
07/01/2024First vesting date: 356 shares vest if Swanson is a director.
10/01/2024Second vesting date: 356 shares vest if Swanson is a director.
01/01/2025Third vesting date: 356 shares vest if Swanson is a director.
04/01/2025Fourth vesting date: 356 shares vest if Swanson is a director.
05/21/2024Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.